COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,158 Articles (22,703 medRxiv, 8,455 bioRxiv)

Most recent first Previous |  Page 1098: Articles 10971-10980  | Next

Estimating the transmissibility of SARS-CoV-2 during periods of high, low and zero case incidence
Golding, N., Price, D. J., Ryan, G., McVernon, J., McCaw, J. M., Shearer, F. M.
10.1101/2021.11.28.21264509 — Posted: 2021-11-29
Partial lockdown on unvaccinated individuals promises breaking of fourth COVID-19 wave in Bavaria
Krebs, T., Moeckel, M. J.
10.1101/2021.11.28.21266959 — Posted: 2021-11-29
Prioritizing interventions for preventing COVID-19 outbreaks in military basic training
Camargo Espana, G. F., Perkins, A., Pollett, S., Smith, M., Moore, S. M., Kwon, P., Hall, T., Beagle, M. H., Murray, C., Hakre, S., Peel, S., Modjarrad, K., Scott, P.
10.1101/2021.11.28.21266969 — Posted: 2021-11-29
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for New Zealand (Aotearoa)
Watson, L. M.
10.1101/2021.11.28.21266967 — Posted: 2021-11-29
Modelling the interplay of SARS-CoV-2 variants in the United Kingdom.
Barreiro, N., Govezensky, T., Ventura, C., Nunez, M., Bolcatto, P., Barrio, R.
10.1101/2021.11.26.21266485 — Posted: 2021-11-28
A systematic scoping review on the impact of the COVID-19 quarantine on the psychological wellbeing of medical students.
Vythilingam, D., Atiomo, W.
10.1101/2021.11.28.21266956 — Posted: 2021-11-28
Outcomes of Anti-Spike Monoclonal Antibody Therapy in Pregnant Women with Mild to Moderate COVID-19
Thilagar, B. P., Ghosh, A. K., Nguyen, J., Theiler, R. N., Wick, M. J., Hurt, R. T., Razonable, R. R., Ganesh, R.
10.1101/2021.11.27.21266942 — Posted: 2021-11-28 Discussion: Onsite
COVID-19 Clinical Characteristics and Outcomes in Children and Adolescents Hospitalized at the University Hospital of the West Indies, Jamaica in 2020-2021
Berry, C.-L. S., Melbourne-Chambers, R. H., Harrison, A. N., Anzinger, J. J., Gordon-Johnson, K.-A. M., Deyde, V. M., Christie, C. D. C.
10.1101/2021.11.26.21266916 — Posted: 2021-11-28
Management and containment of a SARS-CoV-2 Beta variant outbreak at the Malawi University of Science and Technology
Bandawe, G. P., Chigwechokha, P., Kunyenje, P., Kazembe, Y., Mwale, J., Kamaliza, M., Mpakati, M., Nyakanyaka, Y., Makamo, C., Kimu, S., Madanitsa, M., Bitilinyu-Bangoh, J., Nyirenda, T., Luhanga, R., Sambani, M., Mvula, B., Giandhari, J., Pillay, S., Naidoo, Y., Ramphal, U., San, E. J., Tegally, H., Wilkinson, E., de Oliveira, T., Malata, A.
10.1101/2021.11.25.21266298 — Posted: 2021-11-28
DEVELOPMENT AND TESTING OF A LOW-COST INACTIVATION BUFFER THAT ALLOWS DIRECT SARS-COV-2 DETECTION IN SALIVA
Bustos-Garcia, B., Garza-Manero, S., Cano-Dominguez, N., Lopez Sanchez, D. M., Salgado-Montes de Oca, G., Salgado-Aguayo, A., Recillas-Targa, F., Avila-Rios, S., Valdes, J.
10.1101/2021.11.26.21266918 — Posted: 2021-11-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).